nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—Disseminated intravascular coagulation—Ifosfamide—testicular cancer	0.0604	0.0604	CcSEcCtD
Mafenide—Metabolic acidosis—Ifosfamide—testicular cancer	0.0546	0.0546	CcSEcCtD
Mafenide—Metabolic acidosis—Etoposide—testicular cancer	0.0431	0.0431	CcSEcCtD
Mafenide—Acidosis—Ifosfamide—testicular cancer	0.039	0.039	CcSEcCtD
Mafenide—Haemolytic anaemia—Chlorambucil—testicular cancer	0.0262	0.0262	CcSEcCtD
Mafenide—Pancytopenia—Chlorambucil—testicular cancer	0.0194	0.0194	CcSEcCtD
Mafenide—Pain—Carboplatin—testicular cancer	0.0194	0.0194	CcSEcCtD
Mafenide—Pancytopenia—Vinblastine—testicular cancer	0.0178	0.0178	CcSEcCtD
Mafenide—Swelling—Ifosfamide—testicular cancer	0.0178	0.0178	CcSEcCtD
Mafenide—Haemolytic anaemia—Ifosfamide—testicular cancer	0.0174	0.0174	CcSEcCtD
Mafenide—Bone marrow depression—Methotrexate—testicular cancer	0.0151	0.0151	CcSEcCtD
Mafenide—Haemoglobin—Vinblastine—testicular cancer	0.0151	0.0151	CcSEcCtD
Mafenide—Pancytopenia—Bleomycin—testicular cancer	0.0151	0.0151	CcSEcCtD
Mafenide—Haemorrhage—Vinblastine—testicular cancer	0.015	0.015	CcSEcCtD
Mafenide—Haemolytic anaemia—Cisplatin—testicular cancer	0.015	0.015	CcSEcCtD
Mafenide—Burning sensation—Methotrexate—testicular cancer	0.0147	0.0147	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—testicular cancer	0.0142	0.0142	CcSEcCtD
Mafenide—Pancytopenia—Dactinomycin—testicular cancer	0.014	0.014	CcSEcCtD
Mafenide—Swelling—Etoposide—testicular cancer	0.014	0.014	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—testicular cancer	0.0139	0.0139	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—testicular cancer	0.0138	0.0138	CcSEcCtD
Mafenide—Blister—Epirubicin—testicular cancer	0.0133	0.0133	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—testicular cancer	0.0131	0.0131	CcSEcCtD
Mafenide—Face oedema—Cisplatin—testicular cancer	0.013	0.013	CcSEcCtD
Mafenide—Pancytopenia—Ifosfamide—testicular cancer	0.0129	0.0129	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—testicular cancer	0.0129	0.0129	CcSEcCtD
Mafenide—Haemoglobin—Bleomycin—testicular cancer	0.0127	0.0127	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—testicular cancer	0.0127	0.0127	CcSEcCtD
Mafenide—Haemorrhage—Bleomycin—testicular cancer	0.0127	0.0127	CcSEcCtD
Mafenide—Blister—Doxorubicin—testicular cancer	0.0123	0.0123	CcSEcCtD
Mafenide—Pancytopenia—Cisplatin—testicular cancer	0.0111	0.0111	CcSEcCtD
Mafenide—Erythema—Bleomycin—testicular cancer	0.011	0.011	CcSEcCtD
Mafenide—Haemoglobin—Ifosfamide—testicular cancer	0.0109	0.0109	CcSEcCtD
Mafenide—Haemorrhage—Ifosfamide—testicular cancer	0.0108	0.0108	CcSEcCtD
Mafenide—Erythema—Dactinomycin—testicular cancer	0.0103	0.0103	CcSEcCtD
Mafenide—Pancytopenia—Etoposide—testicular cancer	0.0102	0.0102	CcSEcCtD
Mafenide—Pain—Chlorambucil—testicular cancer	0.00996	0.00996	CcSEcCtD
Mafenide—Erythema—Ifosfamide—testicular cancer	0.00944	0.00944	CcSEcCtD
Mafenide—Urticaria—Chlorambucil—testicular cancer	0.00925	0.00925	CcSEcCtD
Mafenide—Pain—Vinblastine—testicular cancer	0.00912	0.00912	CcSEcCtD
Mafenide—Pruritus—Chlorambucil—testicular cancer	0.00824	0.00824	CcSEcCtD
Mafenide—Erythema—Cisplatin—testicular cancer	0.00814	0.00814	CcSEcCtD
Mafenide—Diarrhoea—Chlorambucil—testicular cancer	0.00797	0.00797	CcSEcCtD
Mafenide—Pain—Bleomycin—testicular cancer	0.00771	0.00771	CcSEcCtD
Mafenide—Diarrhoea—Vinblastine—testicular cancer	0.0073	0.0073	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—testicular cancer	0.00726	0.00726	CcSEcCtD
Mafenide—Pain—Dactinomycin—testicular cancer	0.00719	0.00719	CcSEcCtD
Mafenide—Urticaria—Bleomycin—testicular cancer	0.00716	0.00716	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—testicular cancer	0.00672	0.00672	CcSEcCtD
Mafenide—Face oedema—Epirubicin—testicular cancer	0.0067	0.0067	CcSEcCtD
Mafenide—Pain—Ifosfamide—testicular cancer	0.00659	0.00659	CcSEcCtD
Mafenide—Pruritus—Bleomycin—testicular cancer	0.00638	0.00638	CcSEcCtD
Mafenide—Eosinophilia—Methotrexate—testicular cancer	0.00634	0.00634	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—testicular cancer	0.0062	0.0062	CcSEcCtD
Mafenide—Urticaria—Ifosfamide—testicular cancer	0.00612	0.00612	CcSEcCtD
Mafenide—Pancytopenia—Methotrexate—testicular cancer	0.00609	0.00609	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—testicular cancer	0.00594	0.00594	CcSEcCtD
Mafenide—Diarrhoea—Dactinomycin—testicular cancer	0.00575	0.00575	CcSEcCtD
Mafenide—Pancytopenia—Epirubicin—testicular cancer	0.00569	0.00569	CcSEcCtD
Mafenide—Rash—Bleomycin—testicular cancer	0.00568	0.00568	CcSEcCtD
Mafenide—Pain—Cisplatin—testicular cancer	0.00568	0.00568	CcSEcCtD
Mafenide—Dermatitis—Bleomycin—testicular cancer	0.00568	0.00568	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—testicular cancer	0.00549	0.00549	CcSEcCtD
Mafenide—Pruritus—Ifosfamide—testicular cancer	0.00545	0.00545	CcSEcCtD
Mafenide—Rash—Dactinomycin—testicular cancer	0.0053	0.0053	CcSEcCtD
Mafenide—Diarrhoea—Ifosfamide—testicular cancer	0.00527	0.00527	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—testicular cancer	0.00527	0.00527	CcSEcCtD
Mafenide—Pain—Etoposide—testicular cancer	0.0052	0.0052	CcSEcCtD
Mafenide—Haemoglobin—Methotrexate—testicular cancer	0.00515	0.00515	CcSEcCtD
Mafenide—Haemorrhage—Methotrexate—testicular cancer	0.00513	0.00513	CcSEcCtD
Mafenide—Rash—Ifosfamide—testicular cancer	0.00486	0.00486	CcSEcCtD
Mafenide—Dermatitis—Ifosfamide—testicular cancer	0.00485	0.00485	CcSEcCtD
Mafenide—Urticaria—Etoposide—testicular cancer	0.00483	0.00483	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—testicular cancer	0.00482	0.00482	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—testicular cancer	0.0048	0.0048	CcSEcCtD
Mafenide—Diarrhoea—Cisplatin—testicular cancer	0.00454	0.00454	CcSEcCtD
Mafenide—Erythema—Methotrexate—testicular cancer	0.00446	0.00446	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—testicular cancer	0.00446	0.00446	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—testicular cancer	0.00444	0.00444	CcSEcCtD
Mafenide—Pruritus—Etoposide—testicular cancer	0.0043	0.0043	CcSEcCtD
Mafenide—Rash—Cisplatin—testicular cancer	0.00419	0.00419	CcSEcCtD
Mafenide—Dermatitis—Cisplatin—testicular cancer	0.00418	0.00418	CcSEcCtD
Mafenide—Erythema—Epirubicin—testicular cancer	0.00418	0.00418	CcSEcCtD
Mafenide—Diarrhoea—Etoposide—testicular cancer	0.00416	0.00416	CcSEcCtD
Mafenide—Erythema—Doxorubicin—testicular cancer	0.00387	0.00387	CcSEcCtD
Mafenide—Rash—Etoposide—testicular cancer	0.00384	0.00384	CcSEcCtD
Mafenide—Dermatitis—Etoposide—testicular cancer	0.00383	0.00383	CcSEcCtD
Mafenide—Pain—Methotrexate—testicular cancer	0.00312	0.00312	CcSEcCtD
Mafenide—Pain—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Mafenide—Urticaria—Methotrexate—testicular cancer	0.00289	0.00289	CcSEcCtD
Mafenide—Urticaria—Epirubicin—testicular cancer	0.00271	0.00271	CcSEcCtD
Mafenide—Pain—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Mafenide—Pruritus—Methotrexate—testicular cancer	0.00258	0.00258	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Mafenide—Diarrhoea—Methotrexate—testicular cancer	0.00249	0.00249	CcSEcCtD
Mafenide—Pruritus—Epirubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Mafenide—Rash—Methotrexate—testicular cancer	0.0023	0.0023	CcSEcCtD
Mafenide—Dermatitis—Methotrexate—testicular cancer	0.0023	0.0023	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—testicular cancer	0.00223	0.00223	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Mafenide—Rash—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Mafenide—Rash—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
